These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

176 related items for PubMed ID: 15336593

  • 21. Comparison of the effects of raloxifene and low-dose hormone replacement therapy on bone mineral density and bone turnover in the treatment of postmenopausal osteoporosis.
    Dane C, Dane B, Cetin A, Erginbas M.
    Gynecol Endocrinol; 2007 Jul; 23(7):398-403. PubMed ID: 17701771
    [Abstract] [Full Text] [Related]

  • 22. Polymorphisms in the CYP19 and AR genes--relation to bone mass and longitudinal bone changes in postmenopausal women with or without hormone replacement therapy: The Danish Osteoporosis Prevention Study.
    Tofteng CL, Kindmark A, Brändström H, Abrahamsen B, Petersen S, Stiger F, Stilgren LS, Jensen JE, Vestergaard P, Langdahl BL, Mosekilde L, Danish Osteoporosis Prevention Study.
    Calcif Tissue Int; 2004 Jan; 74(1):25-34. PubMed ID: 14517714
    [Abstract] [Full Text] [Related]

  • 23. Vitamin D and HRT: no benefit additional to that of HRT alone in prevention of bone loss in early postmenopausal women. A 2.5-year randomized placebo-controlled study.
    Komulainen M, Tuppurainen MT, Kröger H, Heikkinen AM, Puntila E, Alhava E, Honkanen R, Saarikoski S.
    Osteoporos Int; 1997 Jan; 7(2):126-32. PubMed ID: 9166392
    [Abstract] [Full Text] [Related]

  • 24. Effects of vibration therapy on bone mineral density in postmenopausal women with osteoporosis.
    Ruan XY, Jin FY, Liu YL, Peng ZL, Sun YG.
    Chin Med J (Engl); 2008 Jul 05; 121(13):1155-8. PubMed ID: 18710630
    [Abstract] [Full Text] [Related]

  • 25. Association of the calcitonin gene (CA) polymorphism with bone mass and bone responsiveness to hormone therapy in postmenopausal Korean women.
    Kim JG, Choi YM, Moon SY, Lee JY.
    Menopause; 2003 Jul 05; 10(6):544-9. PubMed ID: 14627864
    [Abstract] [Full Text] [Related]

  • 26. Identification of early postmenopausal women with no bone response to HRT: results of a five-year clinical trial.
    Komulainen M, Kröger H, Tuppurainen MT, Heikkinen AM, Honkanen R, Saarikoski S.
    Osteoporos Int; 2000 Jul 05; 11(3):211-8. PubMed ID: 10824236
    [Abstract] [Full Text] [Related]

  • 27. Evaluation of eNOS gene polymorphisms in relation to BMD in postmenopausal women.
    Firat SC, Cetin Z, Samanci N, Aydin F, Balci N, Gungor F, Firat MZ, Luleci G, Karauzum SB.
    Maturitas; 2009 Aug 20; 63(4):352-6. PubMed ID: 19520527
    [Abstract] [Full Text] [Related]

  • 28. Apolipoprotein E gene polymorphism and bone loss: estrogen status modifies the influence of apolipoprotein E on bone loss.
    Salamone LM, Cauley JA, Zmuda J, Pasagian-Macaulay A, Epstein RS, Ferrell RE, Black DM, Kuller LH.
    J Bone Miner Res; 2000 Feb 20; 15(2):308-14. PubMed ID: 10703933
    [Abstract] [Full Text] [Related]

  • 29. Association of leucine 7 to proline 7 polymorphism in the preproneuropeptide Y with serum lipids in patients with coronary heart disease.
    Erkkilä AT, Lindi V, Lehto S, Laakso M, Uusitupa MI.
    Mol Genet Metab; 2002 Mar 20; 75(3):260-4. PubMed ID: 11914038
    [Abstract] [Full Text] [Related]

  • 30. The effects of progestins on bone density and bone metabolism in postmenopausal women: a randomized controlled trial.
    Liu JH, Muse KN.
    Am J Obstet Gynecol; 2005 Apr 20; 192(4):1316-23; discussion 1323-4. PubMed ID: 15846228
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Bone mineral density, body height, and vitamin D receptor gene polymorphism in middle-aged men.
    Remes T, Väisänen SB, Mahonen A, Huuskonen J, Kröger H, Jurvelin JS, Rauramaa R.
    Ann Med; 2005 Apr 20; 37(5):383-92. PubMed ID: 16179274
    [Abstract] [Full Text] [Related]

  • 33. The changes in circulating osteoprotegerin after hormone therapy in postmenopausal women and their relationship with oestrogen responsiveness on bone.
    Han KO, Choi JT, Choi HA, Moon IG, Yim CH, Park WK, Yoon HK, Han IK.
    Clin Endocrinol (Oxf); 2005 Mar 20; 62(3):349-53. PubMed ID: 15730418
    [Abstract] [Full Text] [Related]

  • 34. Association between polymorphisms in tumor necrosis factor (TNF) and TNF receptor genes and circulating TNF, soluble TNF receptor levels, and bone mineral density in postmenopausal Korean women.
    Kim H, Chun S, Ku SY, Suh CS, Choi YM, Kim JG.
    Menopause; 2009 Mar 20; 16(5):1014-20. PubMed ID: 19369902
    [Abstract] [Full Text] [Related]

  • 35. Influence of modified transdermal hormone replacement therapy on the concentrations of hormones, growth factors, and bone mineral density in women with osteopenia.
    Stanosz S, Zochowska E, Safranow K, Sieja K, Stanosz M.
    Metabolism; 2009 Jan 20; 58(1):1-7. PubMed ID: 19059524
    [Abstract] [Full Text] [Related]

  • 36. Secondary hyperparathyroidism due to hypovitaminosis D affects bone mineral density response to alendronate in elderly women with osteoporosis: a randomized controlled trial.
    Barone A, Giusti A, Pioli G, Girasole G, Razzano M, Pizzonia M, Palummeri E, Bianchi G.
    J Am Geriatr Soc; 2007 May 20; 55(5):752-7. PubMed ID: 17493196
    [Abstract] [Full Text] [Related]

  • 37. Estrogen receptor (ER) gene polymorphism may predict the bone mineral density response to raloxifene in postmenopausal women on chronic hemodialysis.
    Heilberg IP, Hernandez E, Alonzo E, Valera R, Ferreira LG, Gomes SA, Bellorin-Font E, Weisinger JR.
    Ren Fail; 2005 May 20; 27(2):155-61. PubMed ID: 15807179
    [Abstract] [Full Text] [Related]

  • 38. Association of a polymorphism of the transforming growth factor-beta1 gene with genetic susceptibility to osteoporosis in postmenopausal Japanese women.
    Yamada Y, Miyauchi A, Goto J, Takagi Y, Okuizumi H, Kanematsu M, Hase M, Takai H, Harada A, Ikeda K.
    J Bone Miner Res; 1998 Oct 20; 13(10):1569-76. PubMed ID: 9783545
    [Abstract] [Full Text] [Related]

  • 39. Neuropeptide Y signal peptide Pro7 substitution protects against coronary artery atherosclerosis: the Helsinki Sudden Death Study.
    Ilveskoski E, Viiri LE, Mikkelsson J, Pörsti I, Lehtimäki T, Karhunen PJ.
    Atherosclerosis; 2008 Aug 20; 199(2):445-50. PubMed ID: 18054939
    [Abstract] [Full Text] [Related]

  • 40. A follow-up study on the effects of a milk supplement on bone mineral density of postmenopausal Chinese women in Malaysia.
    Ting GP, Tan SY, Chan SP, Karuthan C, Zaitun Y, Suriah AR, Chee WS.
    J Nutr Health Aging; 2007 Aug 20; 11(1):69-73. PubMed ID: 17315084
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.